CAS 1309-37-1|Ferric oxide
| Common Name | Ferric oxide | ||
|---|---|---|---|
| CAS Number | 1309-37-1 | Molecular Weight | 159.69 |
| Density | 5.24 | Boiling Point | / |
| Molecular Formula | Fe2O3 | Melting Point | 1538ºC |
| MSDS | ChineseUSA | Flash Point | >230°F |
| Symbol | GHS02, GHS05 | Signal Word | Danger |
Names
| Name | ferric oxide |
|---|---|
| Synonym | More Synonyms |
Ferric oxide BiologicalActivity
| Description | Ferric oxide, red can be used as an excipient, such as colorant. Pharmaceutical excipients, or pharmaceutical auxiliaries, refer to other chemical substances used in the pharmaceutical process other than pharmaceutical ingredients. Pharmaceutical excipients generally refer to inactive ingredients in pharmaceutical preparations, which can improve the stability, solubility and processability of pharmaceutical preparations. Pharmaceutical excipients also affect the absorption, distribution, metabolism, and elimination (ADME) processes of co-administered drugs[1]. |
|---|---|
| Related Catalog | Research Areas >>OthersSignaling Pathways >>Others >>Others |
| References | [1]. Elder DP, et al. Pharmaceutical excipients - quality, regulatory and biopharmaceutical considerations. Eur J Pharm Sci. 2016 May 25;87:88-99. |
Chemical & Physical Properties
| Density | 5.24 |
|---|---|
| Melting Point | 1538ºC |
| Molecular Formula | Fe2O3 |
| Molecular Weight | 159.69 |
| Flash Point | >230°F |
| Exact Mass | 159.854630 |
| PSA | 43.37000 |
| Stability | Stable. |
| Water Solubility | INSOLUBLE |
Toxicological Information
CHEMICAL IDENTIFICATION |
ACUTE TOXICITY DATA - TYPE OF TEST :
- LDLo - Lowest published lethal dose
- ROUTE OF EXPOSURE :
- Subcutaneous
- SPECIES OBSERVED :
- Mammal - dog
- DOSE/DURATION :
- 30 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- REFERENCE :
- HBAMAK "Abdernalden's Handbuch der Biologischen Arbeitsmethoden." (Leipzig, Ger. Dem. Rep.) Volume(issue)/page/year: 4,1289,1935 ** OTHER MULTIPLE DOSE TOXICITY DATA **
- TYPE OF TEST :
- TCLo - Lowest published toxic concentration
- ROUTE OF EXPOSURE :
- Inhalation
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- 500 ug/m3/24H/61D-C
- TOXIC EFFECTS :
- Brain and Coverings - other degenerative changes Blood - changes in serum composition (e.g. TP, bilirubin, cholesterol) Biochemical - Enzyme inhibition, induction, or change in blood or tissue levels - true cholinesterase
- REFERENCE :
- GISAAA Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- Volume(issue)/page/year: 50(7),73,1985 ** TUMORIGENIC DATA **
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Subcutaneous
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- 135 mg/kg
- REFERENCE :
- PBPHAW Progress in Biochemical Pharmacology. (S. Karger AG, Postfach CH-4009 Basel, Switzerland) V.1- 1965- Volume(issue)/page/year: 14,47,1978 *** REVIEWS *** ACGIH TLV-Not classifiable as a human carcinogen DTLVS* The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 Volume(issue)/page/year: TLV/BEI,1997 ACGIH TLV-TWA 10 mg/m3, Inhalable dust DTLVS* The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 Volume(issue)/page/year: TLV/BEI,1997 IARC Cancer Review:Animal NO EVIDENCE IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- Volume(issue)/page/year: 1,29,1972 IARC Cancer Review:Human Inadequate Evidence IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- Volume(issue)/page/year: 1,29,1972 IARC Cancer Review:Group 3 IMSUDL IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- Volume(issue)/page/year: 7,216,1987 TOXICOLOGY REVIEW ZKKOBW Zeitschrift fuer Krebsforschung und Klinische Onkologie. (Berlin, Fed. Rep. Ger.) V.76-92, 1971-78. For publisher information, see JCROD7. Volume(issue)/page/year: 78,99,1972 *** U.S. STANDARDS AND REGULATIONS *** MSHA STANDARD:NUISANCE PARTICULATES DTLWS* "Documentation of the Threshold Limit Values for Substances in Workroom Air," Supplements. For publisher information, see 85INA8. Volume(issue)/page/year: 3,27,1973 OSHA PEL (Gen Indu):8H TWA 15 mg/m3, total dust CFRGBR Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) Volume(issue)/page/year: 29,1910.1000,1994 OSHA PEL (Gen Indu):8H TWA 5 mg/m3, respirable fraction CFRGBR Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) Volume(issue)/page/year: 29,1910.1000,1994 OSHA PEL (Construc):8H TWA 15 mg/m3, total dust CFRGBR Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) Volume(issue)/page/year: 29,1926.55,1994 OSHA PEL (Construc):8H TWA 5 mg/m3, respirable fraction CFRGBR Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) Volume(issue)/page/year: 29,1926.55,1994 OSHA PEL (Shipyard):8H TWA 15 mg/m3, total dust CFRGBR Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) Volume(issue)/page/year: 29,1915.1000,1993 OSHA PEL (Shipyard):8H TWA 5 mg/m3, respirable fraction CFRGBR Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) Volume(issue)/page/year: 29,1915.1000,1993 *** OCCUPATIONAL EXPOSURE LIMITS *** OEL-ARAB Republic of Egypt:TWA 3 ppm (5 mg/m3) (fume) JAN 1993 OEL-AUSTRALIA:TWA 5 mg/m3 (fume) JAN 1993 OEL-BELGIUM:TWA 2 ppm (5 mg/m3) (fume) JAN 1993 OEL-DENMARK:TWA 3.5 mg/m3 (fume) JAN 1993 OEL-FINLAND:TWA 5 ppm (fume) JAN 1993 OEL-FRANCE:TWA 5 mg/m3 (fume) JAN 1993 OEL-GERMANY:TWA 6 mg/m3 (fume) JAN 1993 OEL-THE NETHERLANDS:TWA 10 mg/m3 JAN 1993 OEL-THE NETHERLANDS:TWA 5 mg/m3 (fume) JAN 1993 OEL-THE PHILIPPINES:TWA 10 mg/m3 (fume) JAN 1993 OEL-POLAND:TWA 5 mg/m3 (fume) JAN 1993 OEL-SWEDEN:TWA 3.5 mg/m3 (fume) JAN 1993 OEL-SWITZERLAND:TWA 2 ppm (5 mg/m3) (fume) JAN 1993 OEL-THAILAND:TWA 10 mg/m3 (fume) JAN 1993 OEL-TURKEY:TWA 10 mg/m3 (fume) JAN 1993 OEL-UNITED KINGDOM:TWA 10 mg/m3 (total dust) JAN 1993 OEL-UNITED KINGDOM:TWA 5 mg/m3 (resp. dust) JAN 1993 OEL-UNITED KINGDOM:TWA 5 mg/m3;STEL 10 mg/m3 (fume) JAN 1993 OEL IN BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV *** NIOSH STANDARDS DEVELOPMENT AND SURVEILLANCE DATA *** NIOSH RECOMMENDED EXPOSURE LEVEL (REL) : NIOSH REL TO IRON OXIDE, dust and fume (as Fe)-air:10H TWA 5 mg/m3 REFERENCE : NIOSH* National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. Volume(issue)/page/year: DHHS #92-100,1992 NIOSH OCCUPATIONAL EXPOSURE SURVEY DATA : NOHS - National Occupational Hazard Survey (1974) NOHS Hazard Code - M1463 No. of Facilities: 41132 (estimated) No. of Industries: 265 No. of Occupations: 153 No. of Employees: 483117 (estimated) NOES - National Occupational Exposure Survey (1983) NOES Hazard Code - M1463 No. of Facilities: 62557 (estimated) No. of Industries: 308 No. of Occupations: 185 No. of Employees: 965275 (estimated) No. of Female Employees: 139397 (estimated)
Safety Information
| Symbol | GHS02, GHS05 |
|---|---|
| Signal Word | Danger |
| Hazard Statements | H225-H318 |
| Precautionary Statements | P210-P280-P305 + P351 + P338 + P310-P370 + P378-P403 + P235 |
| Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Gloves |
| Hazard Codes | Xi:Irritant |
| Risk Phrases | R36/37/38 |
| Safety Phrases | S26 |
| RIDADR | UN 1376 |
| WGK Germany | - |
| RTECS | NO7400000 |
| HS Code | 2821100000 |
Customs
| HS Code | 2821100000 |
|---|
Articles86
More Articles| Optimization of oleylamine-Fe3O4/MWCNTs nanocomposite modified GC electrode for electrochemical determination of ofloxacin. J. Nanosci. Nanotechnol. 14(7) , 5059-69, (2014) Iron oxide (Fe3O4) nanoparticles are prepared by nucleation method using oleylamine (OLA) as the capping agent. The OLA capped Fe3O4 nanoparticles (OLA-Fe3O4) are characterized by Fourier Transform In... | |
| Mesoporous iron oxide nanofibers and their loading capacity of curcumin. J. Nanosci. Nanotechnol. 14(4) , 2871-7, (2014) Mesoporous iron oxide nanofibers were obtained by calcination of electrospun precursors at various temperatures. Their microstructure is influenced by the calcination temperature. As the calcination t... | |
| Imaging specificity of MR-optical imaging agents following the masking of surface charge by poly(ethylene glycol). Biomaterials 34(16) , 4118-27, (2013) The coupling of specific antibodies to imaging agents often improves imaging specificity. However, free amine groups designed for the coupling can cause nonspecific binding of the imaging agents. We r... |
Synonyms
| MFCD00748135 |
| Iron(III) oxide,-100 mesh,(trace metal basis) |
| Iron oxide in |
| Ferric oxide |
| Iron oxide(II,III) |
| Ferric sesquioxide |
| EINECS 215-168-2 |
| Iron(III) oxide |
